ArticleResearch and practice in thrombosis and haemostasis2026
Clinical and Socioeconomic Predictors of In-hospital Mortality in Acute Pulmonary Embolism: A Cross-sectional Study using the US National Inpatient Sample data.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In-hospital mortality from acute pulmonary embolism (PE) remains substantial despite advances in diagnosis and management. Objectives: We sought to evaluate clinical and socioeconomic predictors of in-hospital mortality among adults hospitalized with acute PE in a nationally representative US cohort. Methods: We conducted a cross-sectional study using the US National Inpatient Sample from 2018 to 2021. Adults hospitalized with a primary diagnosis of acute PE were identified using International Classification of Diseases, Tenth Revision, codes. Multivariable logistic regression was used to evaluate patient- and hospital-level predictors of in-hospital mortality. Comorbidity burden was assessed using the continuous Elixhauser comorbidity index. Analyses were performed using STATA 17.0. Results: An estimated 723,579 (weighted) hospitalizations for acute PE were identified, with in-hospital mortality rate of 3%. Mean age was 63 (SD, 16) years. In adjusted analyses, markers of acute physiologic compromise demonstrated the strongest associations with mortality; lactic acidosis was associated with a 7-fold increase in the odds ratio of death (aOR, 7.04; 95% CI, 6.56-7.54). Increasing comorbidity burden was independently associated with mortality, with each 1-point increase in Elixhauser comorbidity index corresponding to a 20% increase in mortality odds ratio. Metastatic cancer, liver disease, arrhythmias, and coagulopathy were also significant predictors. Female sex and selected racial groups-including Black and Asian/Pacific Islander patients-had higher adjusted odds ratio of mortality than White patients. Self-pay status was associated with higher mortality than Medicare, while increasing household income quartiles were associated with progressively lower mortality. Obesity and chronic hypertension were associated with lower adjusted mortality. Conclusion: In this national cohort, in-hospital mortality following acute PE was most strongly associated with acute physiologic derangement and cumulative comorbidity burden. Socioeconomic characteristics were independently associated with mortality, reflecting the multifactorial nature of inpatient outcomes. These findings support a multidimensional approach to risk assessment while highlighting the need for further investigation into mechanisms underlying observed associations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.